| scholarly article | Q13442814 |
| P2093 | author name string | Annesha Lovett | |
| P2860 | cites work | Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes | Q34007580 |
| Is premium support the right medicine for Medicare? | Q34036362 | ||
| The effect of incentive-based formularies on prescription-drug utilization and spending | Q35600907 | ||
| Angiotensin receptor blockers on the formularies of Medicare drug plans | Q36552000 | ||
| Access to cancer drugs in Medicare Part D: formulary placement and beneficiary cost sharing in 2006. | Q36591071 | ||
| Benzodiazepine use and expenditures for Medicare beneficiaries and the implications of Medicare Part D exclusions | Q37194648 | ||
| Through the looking glass: the politics of the Medicare Prescription Drug, Improvement, and Modernization Act. | Q40219001 | ||
| Status report on Medicare Part D enrollment in 2006: analysis of plan-specific market share and coverage | Q42604152 | ||
| The exclusion of benzodiazepine coverage in medicare: simple steps for avoiding a public health crisis | Q46691430 | ||
| Identifying widely covered drugs and drug coverage variation among Medicare part D formularies | Q46780838 | ||
| Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates | Q50181300 | ||
| Medicare Part D and nursing home residents. | Q53287769 | ||
| The FEHBP as a model for a new Medicare program | Q71216043 | ||
| An analysis of availability of Medicare+Choice, commercial HMO, and FEHBP plans in rural areas: implications for Medicare reform | Q73319291 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 47-58 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | American health & drug benefits | Q26842282 |
| P1476 | title | Medicare part d and the federal employees health benefits program: a comparison of prescription drug coverage | |
| P478 | volume | 6 |
Search more.